Trial site
New York Gastroenterology Associates
- 15running trials
- 3closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease8 trials
- Ulcerative colitis5 trials
- Obesity4 trials
- Asthma1 trial
- Childhood cancers1 trial
- Eosinophilic oesophagitis1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Irritable bowel syndrome1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Recruiting11 trials
- Active, not recruiting4 trials
- Completed3 trials
- Lead sponsor
- Janssen Research & Development, LLC8 trials
- Eli Lilly and Company5 trials
- Ellodi Pharmaceuticals, LP1 trial
- Icahn School of Medicine at Mount Sinai1 trial
- Medtronic - MITG1 trial
- and 2 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease6 recruiting
- Obesity3 recruiting
- Ulcerative colitis3 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Irritable bowel syndrome1 recruiting
Closed trials
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
Completed
Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
Site data: ClinicalTrials.govUpdated 13 Nov 2026